Loading provider…
Loading provider…
Rheumatology Physician in Boston, MA
NPI: 1104980762Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get MD Elena's Phone Numberphone_androidMobile
Get MD Elena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 223 | 404 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 109 | 146 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 37 | 39 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up.
Authors: Karen Costenbader, Hensin Tsao, Peter Schur, Alan Fine, Bonnie Bermas
Journal: Int J Clin Pract
Publication Date: 2014-05-23
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.
Authors: Osama Rahma
Publication Date: 2018-09-26
Authors: Rajesh Garg
Journal: JAMA
Lead Sponsor: Brigham and Women's Hospital
Collaborators: Columbia University
Intervention / Treatment: DRUG: Adalimumab, DRUG: Methotrexate, DRUG: Hydroxychloroquine, DRUG: Etanercept, DRUG: Sulfasalazine
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Intervention / Treatment: DRUG: Prednisone, DRUG: Mycophenolate Mofetil, DRUG: Hydroxychloroquine or Chloroquine
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib